Effect of donepezil on transcranial magnetic stimulation parameters in Alzheimer's disease

INTRODUCTION: There is a need for a reliable, noninvasive biomarker for Alzheimer's disease (AD). We assessed whether short-latency afferent inhibition (SAI), a transcranial magnetic stimulation paradigm that assesses cholinergic circuits of the brain, could become such a biomarker. METHODS: Ni...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Yun Tae, Rocchi, Lorenzo, Hammond, Paul, Hardy, Chris JD., Warren, Jason D., Ridha, Basil H., Rothwell, John, Rossor, Martin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857494/
https://www.ncbi.nlm.nih.gov/pubmed/29560413
http://dx.doi.org/10.1016/j.trci.2018.02.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857494/
https://www.ncbi.nlm.nih.gov/pubmed/29560413
http://dx.doi.org/10.1016/j.trci.2018.02.001

Ejemplares similares